Skip to main content

Alexander Bick Archives

VUMC part of major step to achieving precision medicine

Feb. 19, 2024—An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.

Read more


Chic Awearness supports mentoring program for ovarian cancer patients

Jan. 9, 2024—Chic Awearness is now supporting two new ovarian cancer research initiatives at Vanderbilt University Medical Center and providing matching funding for a social worker to coordinate Woman to Woman, a peer mentoring program launched at VUMC in 2023.

Read more


Kidney disease gene also has a protective mutation

Oct. 5, 2023—African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.

Read more


New view of mutations informs disease risk, treatment response

May. 18, 2023—A transcontinental research effort led by scientists from Vanderbilt University Medical Center and the University of Michigan has upended some long-standing assumptions about mutations — how often they occur, what causes them and what they do.

Read more


Research identifies new target that may prevent blood cancer

Apr. 12, 2023—An international coalition of biomedical researchers co-led by Vanderbilt's Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer.

Read more


VUMC researcher selected for Global Scholars Program

Mar. 30, 2023—Vanderbilt researcher P. Brent Ferrell, MD, is leading one of five projects selected by the 2022 Novartis Institutes for BioMedical Research Global Scholars Program.

Read more


Researchers clarify role of blood cell mutations in disease

Feb. 2, 2023—Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.

Read more


Chan Zuckerberg Initiative grant supports single-cell study of rare inherited disease

Jan. 12, 2023—A multidisciplinary team led by Vanderbilt University Medical Center investigator Alexander Bick, MD, PhD, has been awarded a $2 million, four-year grant to study inflammation at the single-cell level in the rare disease RUNX1-FPD.

Read more


Translational Research Forum highlights range of studies

Oct. 27, 2022—The 2022 Vanderbilt Translational Research Forum exemplified the range of studies conducted at Vanderbilt University Medical Center that are translating scientific discovery into clinical practice.

Read more


Three Vanderbilt biomedical researchers named 2022 Pew Scholars

Jun. 15, 2022—Mariana Byndloss, DVM, PhD, and William Wan, PhD, have been named 2022 Pew Scholars in the Biomedical Sciences and Alexander Bick, MD, PhD, was selected to join the 2022 class of Pew-Stewart Scholars for Cancer Research. 

Read more


Gene variants increase risk of kidney failure in veterans of African ancestry with COVID-19: study

Feb. 10, 2022—Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19.

Read more


Five land ASCI Young Physician-Scientist Awards

Apr. 14, 2021—Five Vanderbilt University Medical Center faculty members have received Young Physician-Scientist Awards from the American Society of Clinical Investigation (ASCI), an elite honor society of physician-scientists.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more